Tristel plc (AIM:TSTL)

Market Cap	203.67M +15.4%
Revenue (ttm)	46.46M +10.8%
Net Income	6.64M +2.3%
EPS	0.14 +2.1%
Shares Out	47.92M
PE Ratio	30.73
Forward PE	24.62
Dividend	0.14 (3.35%)
Ex-Dividend Date	Nov 27, 2025

Volume	95,288
Average Volume	103,296
Open	422.40
Previous Close	424.00
Day's Range	415.00 - 428.00
52-Week Range	260.00 - 445.00
Beta	0.25
RSI	54.84
Earnings Date	Mar 2, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 267
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.